233 related articles for article (PubMed ID: 28682925)
1. Therapeutic Drug Monitoring of Gentamicin Peak Concentrations in Critically Ill Patients.
Hodiamont CJ; Janssen JM; de Jong MD; Mathôt RA; Juffermans NP; van Hest RM
Ther Drug Monit; 2017 Oct; 39(5):522-530. PubMed ID: 28682925
[TBL] [Abstract][Full Text] [Related]
2. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
[TBL] [Abstract][Full Text] [Related]
3. Suboptimal aminoglycoside dosing in critically ill patients.
Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
[TBL] [Abstract][Full Text] [Related]
4. A Retrospective Review of the Efficiency of First-Dose Therapeutic Drug Monitoring of Gentamicin, Amikacin, and Vancomycin in the Pediatric Population.
Lim WXS; Chua WBB; Chua JM; Lee Q; Chan JW; Sultana R; Poh BH
J Clin Pharmacol; 2020 Jan; 60(1):7-15. PubMed ID: 31448430
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of gentamicin serum concentrations in obstetrics and gynaecology patients in Namibia.
Singu BS; Mubita M; Thikukutu MM; Mufenda JK; McKenzie SB; Verbeeck RK
Int J Clin Pharm; 2018 Jun; 40(3):520-525. PubMed ID: 29594677
[TBL] [Abstract][Full Text] [Related]
6. Dose Optimization of Gentamicin in Critically Ill Neonates.
Sridharan K; Al Jufairi M; Qader AM; Elsegai OAM
Curr Drug Metab; 2020; 21(4):270-280. PubMed ID: 32394828
[TBL] [Abstract][Full Text] [Related]
7. Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentrations.
Roger C; Nucci B; Molinari N; Bastide S; Saissi G; Pradel G; Barbar S; Aubert C; Lloret S; Elotmani L; Polge A; Lefrant JY; Roberts JA; Muller L
Int J Antimicrob Agents; 2015 Jul; 46(1):21-7. PubMed ID: 25857948
[TBL] [Abstract][Full Text] [Related]
8. Interest of therapeutic drug monitoring of aminoglycosides administered by a monodose regimen.
Ben Romdhane H; Ben Fredj N; Chaabane A; Ben Aicha S; Chadly Z; Ben Fadhel N; Boughattas N; Aouam K
Nephrol Ther; 2019 Apr; 15(2):110-114. PubMed ID: 30660586
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
[TBL] [Abstract][Full Text] [Related]
10. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.
Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL
Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472
[TBL] [Abstract][Full Text] [Related]
11. Clinical audit of gentamicin use by Bayesian pharmacokinetic approach in critically ill children.
Sridharan K; Al Daylami A
J Infect Chemother; 2020 Jun; 26(6):540-548. PubMed ID: 32070645
[TBL] [Abstract][Full Text] [Related]
12. Extended-Interval Dosing of Gentamicin Aiming for a Drug-Free Period in Neonates: A Prospective Cohort Study.
van Maarseveen EM; Sprij A; Touw DJ
Ther Drug Monit; 2016 Jun; 38(3):402-6. PubMed ID: 26836810
[TBL] [Abstract][Full Text] [Related]
13. Comparing 3 methods of monitoring gentamicin concentrations in patients with febrile neutropenia.
Avent ML; Teoh J; Lees J; Eckert KA; Kirkpatrick CM
Ther Drug Monit; 2011 Oct; 33(5):592-601. PubMed ID: 21912332
[TBL] [Abstract][Full Text] [Related]
14. [A priori prediction of gentamicin peak concentrations: Use of a simple and practical tool].
Mignaval F; Fontaine PA; Riché A; Nowak C; Cancel D; Lemaitre F
Pathol Biol (Paris); 2011 Apr; 59(2):79-82. PubMed ID: 20822863
[TBL] [Abstract][Full Text] [Related]
15. Extended-interval gentamicin: population pharmacokinetics in pediatric critical illness.
Lopez SA; Mulla H; Durward A; Tibby SM
Pediatr Crit Care Med; 2010 Mar; 11(2):267-74. PubMed ID: 19770786
[TBL] [Abstract][Full Text] [Related]
16. Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review.
Hodiamont CJ; van den Broek AK; de Vroom SL; Prins JM; Mathôt RAA; van Hest RM
Clin Pharmacokinet; 2022 Aug; 61(8):1075-1094. PubMed ID: 35754071
[TBL] [Abstract][Full Text] [Related]
17. [Gentamicin pharmacokinetics in term newborn: ¿Is it necessary to systematically monitor plasmatic levels?].
Telechea H; Gesuele J; Grosso P; Galarraga F; Guzzo F; Speranza N; Antúnez F; Nanni L; Giachetto G
Rev Chilena Infectol; 2016 Feb; 33(1):7-11. PubMed ID: 26965871
[TBL] [Abstract][Full Text] [Related]
18. Plasma Peak and Trough Gentamicin Concentrations in Hospitalized Horses Receiving Intravenously Administered Gentamicin.
Bauquier JR; Boston RC; Sweeney RW; Wilkins PA; Nolen-Walston RD
J Vet Intern Med; 2015; 29(6):1660-6. PubMed ID: 26426540
[TBL] [Abstract][Full Text] [Related]
19. Effect of analytical inaccuracy on dose adjustment for gentamicin using the Abbottbase Pharmacokinetic Systems.
Bouzas L; Hermida J; Tutor JC
Clin Lab; 2004; 50(3-4):187-91. PubMed ID: 15074474
[TBL] [Abstract][Full Text] [Related]
20. Impact of clinical decision support guidelines on therapeutic drug monitoring of gentamicin in newborns.
Fonzo-Christe C; Guignard B; Zaugg C; Coehlo A; Posfay-Barbe KM; Gervaix A; Desmeules J; Rollason V; Combescure C; Corbelli R; Rimensberger P; Pfister R; Bonnabry P
Ther Drug Monit; 2014 Oct; 36(5):656-62. PubMed ID: 24690586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
